Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Comparative Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro Tetravalent Inactivated Split Influenza Vaccine, Solution for Intramuscular Injection, FSUE SPbSRIVS FMBA of Russia, in Volunteers Aged 18-60 Years

NCT05869201 is registered in ClinicalTrials.gov with St. Petersburg Research Institute of Vaccines and Sera as lead sponsor.

NCT NCT05869201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05869201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Comparative Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro Tetravalent Inactivated Split Influenza Vaccine, Solution for Intramuscular Injection, FSUE SPbSRIVS FMBA of Russia, in Volunteers Aged 18-60 Years
Lead sponsor
St. Petersburg Research Institute of Vaccines and Sera
Phase
Phase 2/3
Overall status
Completed
Start date
October 6, 2020
Completion date
December 8, 2020
Enrollment
450 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza viral infections, influenza, human, vaccination; infection, vaccine reaction